Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes

Eliana Mariño(Discovery Institute), James L. Richards(Discovery Institute), Keiran H McLeod(Discovery Institute), Dragana Stanley(Central Queensland University), Yu Anne Yap(Discovery Institute), Jacinta Knight(Discovery Institute), Craig I. McKenzie(Discovery Institute), Jan Kranich(Ludwig-Maximilians-Universität München), Ana Carolina Oliveira(Universidade Federal do Rio de Janeiro), Fernando J. Rossello(Australian Regenerative Medicine Institute), Balasubramanian Krishnamurthy(St Vincents Institute of Medical Research), Christian M. Nefzger(Australian Regenerative Medicine Institute), Laurence Macia(The University of Sydney), Alison N. Thorburn(Discovery Institute), Alan G. Baxter(James Cook University), Grant Morahan(Harry Perkins Institute of Medical Research), Lee H. Wong(Discovery Institute), José M. Polo(Australian Regenerative Medicine Institute), Robert J. Moore(Discovery Institute), Trevor Lockett(CSIRO Health and Biosecurity), Julie M. Clarke(CSIRO Health and Biosecurity), David L. Topping(CSIRO Health and Biosecurity), Leonard C. Harrison(Walter and Eliza Hall Institute of Medical Research), Charles R. Mackay(Discovery Institute)
Nature Immunology
March 27, 2017
Cited by 681Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis